Trial · NCT00631657
Participant flow24
How many started, completed or left each group, period by period.
1 to 20 of 24
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| 6-Month Treatment Period | STARTED | Esmirtazapine 4.5 mg/Esmirtazapine 4.5 mg | 344 | |
| 6-Month Treatment Period | STARTED | Esmirtazapine 4.5 mg/Placebo | 0 | |
| 6-Month Treatment Period | STARTED | Placebo/Placebo | 116 | |
| 6-Month Treatment Period | Treated | Esmirtazapine 4.5 mg/Esmirtazapine 4.5 mg | 342 | |
| 6-Month Treatment Period | Treated | Esmirtazapine 4.5 mg/Placebo | 0 | |
| 6-Month Treatment Period | Treated | Placebo/Placebo | 115 | |
| 6-Month Treatment Period | COMPLETED | Esmirtazapine 4.5 mg/Esmirtazapine 4.5 mg | 203 | |
| 6-Month Treatment Period | COMPLETED | Esmirtazapine 4.5 mg/Placebo | 0 | |
| 6-Month Treatment Period | COMPLETED | Placebo/Placebo | 66 | |
| 6-Month Treatment Period | NOT COMPLETED | Esmirtazapine 4.5 mg/Esmirtazapine 4.5 mg | 141 | |
| 6-Month Treatment Period | NOT COMPLETED | Esmirtazapine 4.5 mg/Placebo | 0 | |
| 6-Month Treatment Period | NOT COMPLETED | Placebo/Placebo | 50 | |
| 7-Day Discontinuation Period | STARTED | Esmirtazapine 4.5 mg/Esmirtazapine 4.5 mg | 67 | |
| 7-Day Discontinuation Period | STARTED | Esmirtazapine 4.5 mg/Placebo | 137 | |
| 7-Day Discontinuation Period | STARTED | Placebo/Placebo | 66 | |
| 7-Day Discontinuation Period | Treated | Esmirtazapine 4.5 mg/Esmirtazapine 4.5 mg | 66 | |
| 7-Day Discontinuation Period | Treated | Esmirtazapine 4.5 mg/Placebo | 136 | |
| 7-Day Discontinuation Period | Treated | Placebo/Placebo | 65 | |
| 7-Day Discontinuation Period | COMPLETED | Esmirtazapine 4.5 mg/Esmirtazapine 4.5 mg | 65 | |
| 7-Day Discontinuation Period | COMPLETED | Esmirtazapine 4.5 mg/Placebo | 136 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00631657/flow